1st Department of Radiology, Radiation Oncology Unit, Aretaieion University Hospital, 15772 Athens, Greece.
Department of Pathology, Medical School, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Curr Oncol. 2022 Jun 15;29(6):4274-4284. doi: 10.3390/curroncol29060342.
Microenvironmental conditions control the entrance and thriving of cytotoxic lymphocytes in tumors, allowing or preventing immune-mediated cancer cell death. We investigated the role of tumor-infiltrating lymphocyte (TIL) density in the outcome of radiotherapy in a series of squamous cell head−neck tumors (HNSCC). Moreover, we assessed the link between markers of hypoxia and TIL density. One-hundred twenty-one patients with HNSCC treated prospectively with radical radiotherapy/chemo-radiotherapy were analyzed. The assessment of TIL density was performed on hematoxylin and eosin biopsy sections before radiotherapy. TIL density ranged from 0.8 to 150 lymphocytes per ×40 optical field (median 27.5). Using the median value, patients were grouped into two categories of low and high TIL density. Early T-stage tumors had a significantly higher TIL density (p < 0.003), but we found no association with N-stage. Overexpression of HIF1α, HIF2α, and CA9 was significantly linked with poor infiltration by TILs (p < 0.03). A significant association of high TIL density with better disease-specific overall survival and improved locoregional relapse-free survival was noted (p = 0.008 and 0.02, respectively), which was also confirmed in multivariate analysis. It is concluded that HNSCC phenotypes that allow for the intratumoral accumulation of lymphocytes have a better outcome following radical radiotherapy/chemo-radiotherapy. Intratumoral-activated HIF- and CA9-related pathways characterize immunologically cold tumors and may be used as targets for therapeutic interventions.
微环境条件控制细胞毒性淋巴细胞进入肿瘤并使其茁壮成长,从而允许或阻止免疫介导的癌细胞死亡。我们研究了肿瘤浸润淋巴细胞 (TIL) 密度在一系列鳞状细胞头颈部肿瘤 (HNSCC) 放射治疗结果中的作用。此外,我们评估了缺氧标志物与 TIL 密度之间的联系。对 121 例接受根治性放疗/放化疗的 HNSCC 患者进行前瞻性分析。在放疗前对苏木精和伊红活检切片进行 TIL 密度评估。TIL 密度范围为 0.8 至 150 个淋巴细胞/×40 光学场(中位数为 27.5)。使用中位数将患者分为 TIL 密度低和高两类。早期 T 期肿瘤的 TIL 密度明显更高(p < 0.003),但我们未发现与 N 期有关。HIF1α、HIF2α 和 CA9 的过表达与 TIL 浸润不良显著相关(p < 0.03)。高 TIL 密度与更好的疾病特异性总生存率和改善的局部区域无复发生存率显著相关(p = 0.008 和 0.02),多变量分析也证实了这一点。综上所述,允许淋巴细胞在肿瘤内积聚的 HNSCC 表型在接受根治性放疗/放化疗后具有更好的疗效。肿瘤内激活的 HIF 和 CA9 相关途径可用于表征免疫冷肿瘤,并可作为治疗干预的靶点。